Warberg Asset Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-73,422
Closed -$777K – 222
2026
Q1
$777K Hold
73,422
– – 0.13% 65
2025
Q4
$769K Hold
73,422
– – 0.09% 67
2025
Q3
$759K Sell
73,422
-1,000
-1% -$10.3K 0.12% 67
2025
Q2
$765K Buy
74,422
+2
+0% +$20 0.12% 70
2025
Q1
$750K Buy
+74,420
New +$748K 0.12% 72

Other funds holding TDAC

Warberg Asset Management's TDAC Position: Q2 2026 in Review

Warberg Asset Management sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 73,422 shares — an estimated $777K sold.

Warberg Asset Management first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $777K in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Warberg Asset Management reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Warberg Asset Management sold 73,422 Translational Development Acquisition Corp shares in Q2 2026, an estimated $777K.
  • Warberg Asset Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • Warberg Asset Management's Translational Development Acquisition Corp position peaked at $777K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Warberg Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.